What motivated the shift into the veterinary space? Topelius: Actually, we started with veterinary applications. When we founded the company, our first application areas w ...

Novo, the maker of the obesity drug Wegovy, has repeatedly warned about the risks of compounded and knock-off versions of GLP ...

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

Compounded semaglutide is a medication that’s custom-made by a compounding pharmacy. It contains the active ingredient semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist.

The runaway popularity of GLP-1 medications like Ozempic and Wegovy for weight loss and diabetes management led to a nationwide shortage that lasted more than a year—and created the perfect conditions ...

Compounding is the act of mixing, combining, or altering ingredients to tailor a medication to an individual’s needs. Generally, compounding a medication is done by a licensed pharmacist, a licensed ...

Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging ...

Structure CEO warns compounded weight-loss drugs could threaten new obesity treatments as the company prepares to bring its ...

Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient choice ...

In these cases, compounded drugs are filling a specific need. While many GLP-1s were on the FDA’s shortage list, as of earlier this year, the FDA has removed them, meaning that the compounding of ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...